9999999997-14-004289.txt : 20140325 9999999997-14-004289.hdr.sgml : 20140325 20140325140804 ACCESSION NUMBER: 9999999997-14-004289 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20140325 DATE AS OF CHANGE: 20140325 20140325 20140325 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 14715518 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C$P(#`@;V)J#3P\+TQI;F5A7!E+UA2968O5ULQ(#(@,5T^/G-T#0IE;F1S M=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@("`@#0HR M,B`P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22`X-"],(#8X+TQE;F=T M:"`V,2]3(#,X/CYS=')E86T-"FC>8F!@8&9@8.)G``(.-P94P`C$+`P<#7!E+T-A=&%L;V<^/@UE;F1O8FH-,3(@ M,"!O8FH-/#PO0V]N=&5N=',@,30@,"!2+T-R;W!";WA;,"`P(#8Q,B`W.3)= M+TUE9&EA0F]X6S`@,"`V,3(@-SDR72]087)E;G0@."`P(%(O4F5S;W5R8V5S M(#$V(#`@4B]2;W1A=&4@,"]4>7!E+U!A9V4^/@UE;F1O8FH-,3,@,"!O8FH- M/#PO1FEL=&5R+T9L871E1&5C;V1E+T9ILYO?9Y)NM19ZM-"$#J&DTF]7PRB M*(%!P!7.QW%P+N.E0Z>ZS(O'#UE>FA9NS6^XJTM=?738K2X-V,7:U9;=U4^K"N>X])86,OEA=Y*MQM2D,<)9:4W['[QS[^2B6*#?Y MSM8-^W$TBAMTHEM#,>?:7U>K>IU7&W:?5^.JS9_>IWG3VLNM;B"0)UWHHNF2 MONHN0DCD]?#3$J&L>3".V1,]++VVVW8A(PYD$??[L1$6!`'X&(HXMUZNH*3L MGK3B6$$L!"B5N!4D0Q=%_F$8^CCT4XS/BJ+8H7V%ON+!?$__#+%&_^0N5ZK$ MSX%[@G.0KV=)<<0@Z/Q=G>5[A1@_%R)7;Q/BJQH,SV@PD>^3X%O5)_F)^L+X M/]1W,+H/6O_6W^FIO^53]3G-=0HB7?4W[3MX-26H@EYA'J<,?SHH[V\C!5'O MX]VIJ6-VK#[2]>D_XR;%WO((14PT*96YD7[+N M-DX1*T6!35'(,AVS4"2O1&V2W^@7=WB1;"=.'$0F*?+,S)DS0W^Z6C-X:`9? MTL&G-/6!0;H;,!\\_,.OQ(/8&]-Q`.GCP(,'_$]S]7@:$'#2?P=L#"ZC+(1T M9E?27^W`'=$D.;YUJ>>Q1!VW@Z?!=W*W6J9SQPUH0F:P=MR0QB1U*".3U*S. M[2(X?Z>_#=R(QG%XCNE%%E,-%.9Z/KV[7:9+!W<'"`"3U0S0R(A&Y*_IU\GJ MRDY@>G-]O5ROES$U M12%-HE6+3P8A6\#,L0KB^G7.71T(5%S2P],IBG<+(`E(\6^ M3P(+B)DX)>B-&!A-1A_S]R>O)7^&/_99_9CEO)4BSXH&EF5.-41$O?A]`YA1 M+S@1W$(4'%85!<]%7U%4+DP7OXR\"+U4^VE\(D#RSZ6/WH?2#XST%6=68<%1 MT]YY4+%R"_<%&*UF$VQ8CA^''M'!.6,:DI,(U:N08)Q5?:CJ3/*M<]0UP[R/ M0I-B92#L60N-@:;=*,01$1)/0E9"=C@4B"Q%A3@A*:$MM[R&VQ89\8.-ZW<: M,-"]_]])S7^TO)&B?("\*G=BRTLIL@)DS3-IK'#'1=]*";NJ!E'BTZRCN<[? MR#OQ=]SY:]55E2`D\.>\:+?H[JZNU'FL.+GG,'_>BXV0#<@*,E@X,:D<.B:U MW=*[K2Q<4@+SW&^PP\QO`>TL^*9NL_H%&#,U2<^[$`[.=,BLB^"XF!%&OF2- M`:KYH>8-M@L4`UK,E\0LZT[418UCKQ>E0C MN[A#)5+N,XD/T1S#1O@SL8UZ$\9"GPY&M*?PH\T*L1.\@:PYSVA>/3YRXW9, M8W;,5]RS$1O0.E?[,=D[46:EGF@[JH>.B!6SMF9DIO)H/=;(9QZ'77>SU;&H M.=]61D%0[9"04T$AYB270PCACJ[IE$(8^O=D<^_E#N\'"+%Y@:VN%T8A9][US%9(F+ZJ&8ZU00!)0(5NL MRN)EJ$O'=E06?=08='V)UX3:@AN1DT3YV+#&YR$E/9J]AW8.WMFJ'!-2%-63 M:A'\&4LA(;IDX4D4!<:I5R1L.!:-$V"G*'C6X"(CNJLE1/%@@H\P!>'[.5#N M&<)TJU%3*1YQC=>BVD)SX+F2]O:SO6D-W+OW@RUVUO=G&Q=`UW5LBV8>Q0;) MDB#$=W)?5^W#WK[J&XJ9QD,[\%6QZ*#,;1!H#_1M<73"?B[<&:\B[QH0VK-Q M3[%8G1C)$XU2\5#UGE>R[CI0PBXHPI0R_JBIW@A[B!S739N56J"&28WRD8>H M[X(_Z"Z5M7)?U4*^?.Y8OD#\VT''S7?+RS=%I(]]E>,@P%^5Y*>A5JAYC//2 MS"WCUVHYP?WT;/FF@_E/PY#5&]@>KS"O3@8F@U8G0:^3J-<)?F;\T,HN_VN> MUURB'E#8`1Y/8N\(\BX-\W3POP`#`$X@TQ<-"F5N9'-TFMC.60B/SX*/'@Z>&UP;65T82!X;6QN#IX;7!T:STB061O8F4@6$U0($-O&UL M;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(CX*("`@("`@ M("`@/'!D9CI0&UP34TZ26YS=&%N8V5)1#YU=6ED.C0W.3%A,C1C M+3=A.&,M-&,T9"UB83,S+3EC935A-3&UP34TZ26YS=&%N8V5) M1#X*("`@("`@/"]R9&8Z1&5S8W)I<'1I;VX^"B`@(#POJ'5!:DZ@7!E+UA2968O5ULQ(#(@,5T^ M/G-T